Acascade synthesis protocol for glycosides of 1,4-butanediol monomesylate, as anticancer drug candidates, is proposed. All obtained compounds are characterized by FT-IR, 1H and 13C NMR spectroscopy technique after separation by column chromatography. Cytotoxicity of the obtained glucosides and galactosides of 1,4-butanediol monomesylate on K562 human erythroleukemia cell line and normal peripheral blood mononuclear cells (PBMCs) is also investigated. Compared to the commercial anticancer drugs such as busulfan and doxorubicin, these compounds indicate promising results against the test cells. It is suggested that these new anticancer agents can be a potential replacement for the current drugs since they have relatively convenient synthetic procedure and higher effectiveness.
![](http://media.springernature.com/m312/springer-static/image/art%3A10.1007%2Fs11094-022-02555-9/MediaObjects/11094_2022_2555_Fig1_HTML.jpg)
![](http://media.springernature.com/m312/springer-static/image/art%3A10.1007%2Fs11094-022-02555-9/MediaObjects/11094_2022_2555_Sch1_HTML.jpg)
![](http://media.springernature.com/m312/springer-static/image/art%3A10.1007%2Fs11094-022-02555-9/MediaObjects/11094_2022_2555_Fig2_HTML.jpg)
![](http://media.springernature.com/m312/springer-static/image/art%3A10.1007%2Fs11094-022-02555-9/MediaObjects/11094_2022_2555_Fig3_HTML.jpg)
![](http://media.springernature.com/m312/springer-static/image/art%3A10.1007%2Fs11094-022-02555-9/MediaObjects/11094_2022_2555_Fig4_HTML.jpg)
![](http://media.springernature.com/m312/springer-static/image/art%3A10.1007%2Fs11094-022-02555-9/MediaObjects/11094_2022_2555_Fig5_HTML.jpg)
Similar content being viewed by others
References
B. L. Sorg, W. E. Hull, H-C. Kliem, et al., Carbohydr. Res., 340, 181 – 189 (2005).
G. M. Dubowchik and M. A. Walker, Pharm. Ther., 83, 67 – 123 (1999).
V. P. Torchilin, Eur. J. Pharm. Sci., 11, 81 – 91 (2000).
L. G. Strauss and P. S. Conti, J. Nucl. Med., 32, 623 – 648 (1991).
K. D. Bagshawe, Cell. Biophys., 24, 83 – 91 (1994).
A. Pałasz, D. Cież, B. Trzewik, et al., Top. Curr. Chem., 377, 19 (2019).
A. Diez-Sampedro, M. P. Lostao, E. M. Wright, and B. A. Hirayama, J. Membr, Biol., 176, 111 – 117 (2000).
J. Pohl, B. Bertram, P. Hilgard, et al., Cancer. Chemother. Pharmacol., 35, 364 – 370 (1995).
E. Briasoulis, I. Judson, N. Pavlidis, et al., J. Clin. Oncol., 18, 3535 – 3544 (2000).
T. E. Ciuleanu, A. V. Pavlovsky, G. Bodokry, et al., Eur. J. Cancer., 45, 1589 – 1596 (2009).
L. F. Tietze, J. Marian von Hof, B. Krewer, et al., Chem. Med. Chem., 3, 1946 – 1955 (2008).
K. D. Bagshawe, Cell. Biophys., 24, 83 – 91 (1994).
A. Guerrero, R. Guiho, N. Herranz, et al., Aging Cell., 19, e13133 (2020).
K. N. Syrigos, G. Rowlinson-Busza, and A. A. Epenetos, Int. J. Cancer., 78, 712 – 719 (1998).
I. Buggia, F. Locatelli, M. R. Regazzi, and M. Zecca, Ann. Pharmacother., 28, 1055 – 1062 (1994).
M. Pishnamazi, S. Zabihi, S. Jamshidian, et al., J. Mol. Liq., 317, 113954 (2020).
D. Kawashima, M. Asai, K. Katagiri, et al., Cell. Stress. Chaperon., 14, 535 – 543 (2009).
K. Begna, A. Abdelatif, S. Schwager, et al., Blood. Cancer. J., 6, e427 (2016).
S.-S. Lee, S-H. Jung, Y. R. Do, et al., Yonsei. Med. J., 61, 452 – 459 (2020).
M.W. N. Deininger, J. M. Goldman, and J. V. Melo, Blood., 96, 3343 – 3356 (2000).
C. M. Zwaan, G. J. L. Kaspers, R. Pieters, et al., Blood., 99, 245 – 251 (2002).
C. Oslakovic, The Regulation of Blood Coagulation by High- Density Lipoprotein articles, Lund University (2010), No. 67.
C. B. Andreasen and K. S. Latimer, Avian Dis., 33, 163 – 167 (1989).
N. Singh, J. Kaur, P. Kumar, et al., Parasitol. Res., 105, 1317 – 1325 (2009).
K. S. Korgaonkar and S. S. Ranade, Can. J. Microbiol., 12, 185 – 190 (1966).
H. L. Bank, In Vitro Cell. Dev. Biol. Plant., 24, 266 – 273 (1988).
B. Helferich and J. Werner, Chem. Ber., 75B, 1446 – 1452 (1942).
C. E. Redemann and C. Niemann, Org. Synth., 22, 1 (1942).
J. P. Praly and G. Descotes, Tetrahedron Lett., 23, 849 – 852 (1982).
G. Zemplén and A. Kunz, Ber. Dtsch. Chem. Ges., 56, 1705 – 1710 (1923).
J. C. Stockert, R. W. Horobin, L. L. Colombo, and A. Blázquez- Castro, Acta. Histochem., 120, 159 – 167 (2018).
N. Noroozi Pesyan, H. Rashidnejad, M. A. Esmaeili, E. Safari, T. Tunç, M. Alilou, R. Safavi-Sohi, E. Şahin, J. Chin. Chem. Soc., 67, 1679 – 1695 (2020).
A. Bahuguna, I. Khan, V. K. Bajpai, and S. C. Kang, Bangladesh J. Pharmacol., 12, 115 – 118 (2017).
S. Aykul and E. Martinez-Hackert, Anal. Biochem., 508, 97 – 103 (2016).
F. Denizot and R. Lang, J. Immunol. Methods., 89, 271 – 277 (1986).
L. L.-Y. Chan, T. Smith, K. A. Kumph, et al., Cytotechnology, 68, 2015 – 2025 (2016).
N. A. Samad, A. B. Abdul, R. Abdullah, et al., Int. J. Pharm. Pharm. Sci., 7, 298 – 302 (2015).
Acknowledgements
The authors gratefully acknowledge the Urmia University and Urmia University of Medical Science for supporting this work.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Rashidnejad, H., Kordi, M.A., Pesyan, N.N. et al. Cascade Synthesis of 1,4-Butanediol Monomesylate Glycoconjugates: Anticancer Candidates for Leukemia. Pharm Chem J 55, 1177–1183 (2022). https://doi.org/10.1007/s11094-022-02555-9
Received:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11094-022-02555-9